Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
Sun Yat-sen University
Sun Yat-sen University
Merck Sharp & Dohme LLC
Alliance for Clinical Trials in Oncology
Wake Forest University Health Sciences
Sun Yat-sen University
NRG Oncology
SWOG Cancer Research Network
UNICANCER
Xynomic Pharmaceuticals, Inc.
Gustave Roussy, Cancer Campus, Grand Paris
Telix Pharmaceuticals (Innovations) Pty Limited
University College, London